SOURCE: Celsion Corporation

Celsion Corporation

November 08, 2011 08:00 ET

Celsion to Present at Upcoming Investor Conferences in November

LAWRENCEVILLE, NJ--(Marketwire - Nov 8, 2011) - Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that management will present at the following upcoming investor conferences during the month of November 2011.

Conference: Brean Murray, Carret & Co. 2011 Life Sciences Summit
Date: Monday, November 14, 2011 in New York, NY
The Brean Murray conference will allow institutional investors to meet with management but does not include a formal presentation.

Conference: Lazard Capital Markets 8th Annual Healthcare Conference
Date: Tuesday, November 15, 2011 at 4:30 p.m. Eastern time in New York, NY

Conference: Piper Jaffray 23rd Annual Healthcare Conference
Date: Wednesday, November 30, 2011 at 4:00 p.m. Eastern time in New York, NY

A live audio-only webcast of the presentations will be available on Celsion's website at The webcast will be archived on the same site for replay following the conference.

About Celsion Corporation

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, and the North Shore Long Island Jewish Health System.

For more information on Celsion, visit our website:

Contact Information

  • Investor Contact

    David Pitts
    Argot Partners
    Email Contact